GTCR Completes Acquisition of Zentiva, a Leading European Generics Pharmaceutical Company
GTCR to support Zentiva's next phase of growth, building on its strong foundation of quality, scale and market leadership CHICAGO and PRAGUE, April 9, 2026 /PRNewswire/ -- GTCR, a leading private equity firm, announced today that it has closed the previously announced acquisition of...
View original →